Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Biogen Japan Sets to Quadruple Sales in 2 Years: New Chief
May 19, 2015
- Meiji Holdings Aims at Sales of 180 Billion Yen and 30% Overseas Sales Ratio in Pharma Business by FY2017
May 19, 2015
- Japan’s Biosimilar Market to Rise to 31.4 Billion Yen in 2017: Fuji Keizai
May 19, 2015
- Sanofi Launches Menactra, Preventive Vaccine for Invasive Meningococcal Diseases
May 19, 2015
- Takeda Sees Lower Japan Sales for FY2015 on Generic Pressure
May 18, 2015
- Takeda Incurs Huge Red Ink on Actos Settlement, CEO Says Financial Uncertainty Lessened
May 18, 2015
- Daiichi Sankyo Exits Global Hybrid Biz Model, Now Focuses on Innovation
May 18, 2015
- Takeda Discontinues Development of Bipolar Disorder Treatment TAK-375SL
May 18, 2015
- Masanobu Kambara Becomes UCB Japan President
May 18, 2015
- Mochida Terminates License Deal with US Merck for Type 2 Diabetes Treatment
May 18, 2015
- MTPC Files Remicade for Kawasaki Disease
May 18, 2015
- Daiichi Sankyo Profit Quintuples on Gains from Ranbaxy-Sun Merger
May 15, 2015
- Eisai Earnings Pummeled by Generic Erosions in Japan, US
May 15, 2015
- Mitsubishi Chemical Group to Strengthen Presence in Field of Regenerative Medicine by Acquiring Clio Inc.
May 15, 2015
- Vital KSK Holdings Names Taisuke Murai as President
May 15, 2015
- Kyorin Holdings Names Minoru Hogawa as Next President
May 15, 2015
- Wider Indications Will Give Edge to Plavix AGs: Nichi-Iko Pres.
May 14, 2015
- Takeda Halts PIII Study of Aurora A Kinase Inhibitor for Peripheral T-cell Lymphoma
May 14, 2015
- Blopress AG Gives Lift to ASKA Sales and Profits
May 13, 2015
- Ono’s Operating Profit Declines 40%; NHI Price Reductions, Generics Had Major Negative Impact
May 13, 2015
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…